top of page
All posts
Alzheimer's
ANVISA
Author: Allan Matsui
Author: Jairo Utimi
Author: Claudia Cilento
Author: Nilva Bortoleto
BPF
Cannabidiol
Cancer
Cannabis
Coronavirus
Covid-19
challenges
Epilepsy
pharmaceutical
IFA
pharmaceutical industry
Inovatie
medicines
opportunities
Parkinson
pharmaceuticals
pharmaceutical industry
Author: Camille Rodrigues da Silva
Incremental innovation
Investments
Marketing
News
Incremental innovation
Good Manufacturing Practices
Search
Challenges in the development and registration of biosimilars
Jun 27, 2024
Six suggestions for a successful Advisory Board
Aug 4, 2023
What is required to file a drug patent application?
Jul 9, 2023
What are the main differences between the ICH guides and the ANVISA requirements?
Jun 26, 2023
COVID-19: What facilities is ANVISA providing at this time of crisis?
Feb 9, 2021
E-BOOKS
CONTEÚDOS EXCLUSIVOS PARA AUXILIAR EM
SEU TRABALHO
Acesse
bottom of page
